OncoGenex Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- OncoGenex Pharmaceuticals's estimated annual revenue is currently $5M per year.
- OncoGenex Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- OncoGenex Pharmaceuticals has 32 Employees.
- OncoGenex Pharmaceuticals grew their employee count by -14% last year.
OncoGenex Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | VP Clinical Operations | Reveal Email/Phone |
4 | VP, Head Medical Affairs | Reveal Email/Phone |
5 | VP, CMC | Reveal Email/Phone |
6 | VP, Process Control and QA | Reveal Email/Phone |
7 | SVP, CMC and Regulatory CMC | Reveal Email/Phone |
8 | VP, Clinical Research | Reveal Email/Phone |
9 | EVP, Commercial | Reveal Email/Phone |
10 | Senior Director, Biometrics | Reveal Email/Phone |
OncoGenex Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 5 | 0% | N/A | N/A |
#2 | $0.9M | 5 | 0% | N/A | N/A |
#3 | $5.1M | 30 | 11% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 41 | 5% | $16M | N/A |
#7 | $1.1M | 11 | 83% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 8 | 100% | N/A | N/A |
What Is OncoGenex Pharmaceuticals?
Achieve Life Sciences is a specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic.
keywords:N/A
N/A
Total Funding
32
Number of Employees
$5M
Revenue (est)
-14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
OncoGenex Pharmaceuticals News
2022-04-06 - Targeted Cancer Therapies Market 2022 Size, Share, Challenges, and Future
Business Outlook to 2028 | Abbott,
... GlaxoSmithKline plc, AstraZeneca PLC, OncoGenex Pharmaceuticals Inc., Pfizer, Inc., AVEO Pharmaceuticals Inc., and CYTOKINETICS INC.
2022-03-30 - Global Pharma, Biotech and Diagnostics Option and ...
Global Pharma, Biotech and Diagnostics Option and Evaluation Deals Report/Directory 2021: ... Case study 7: Teva - OncoGenex Pharmaceuticals
2022-03-22 - Targeted Cancer Therapies Market Expected to Expand at a ...
Abbott Laboratories, Bayer AG, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, AstraZeneca PLC, OncoGenex Pharmaceuticals Inc., Pfizer,...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6M | 32 | 10% | N/A |
#2 | $5.2M | 32 | 0% | N/A |
#3 | $8.2M | 32 | 3% | N/A |
#4 | $3.7M | 32 | N/A | N/A |
#5 | $4.9M | 32 | -11% | $7.1M |